Selectivity and Kinetic Requirements of HDAC Inhibitors as Progranulin Enhancers for Treating Frontotemporal Dementia

Angela She, Iren Kurtser, Surya A. Reis, Krista Hennig, Jenny Lai, Audrey Lang, Wen Ning Zhao, Ralph Mazitschek, Bradford C. Dickerson, Joachim Herz, Stephen J. Haggarty

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Frontotemporal dementia (FTD) arises from neurodegeneration in the frontal, insular, and anterior temporal lobes. Autosomal dominant causes of FTD include heterozygous mutations in the GRN gene causing haploinsufficiency of progranulin (PGRN) protein. Recently, histone deacetylase (HDAC) inhibitors have been identified as enhancers of PGRN expression, although the mechanisms through which GRN is epigenetically regulated remain poorly understood. Using a chemogenomic toolkit, including optoepigenetic probes, we show that inhibition of class I HDACs is sufficient to upregulate PGRN in human neurons, and only inhibitors with apparent fast binding to their target HDAC complexes are capable of enhancing PGRN expression. Moreover, we identify regions in the GRN promoter in which elevated H3K27 acetylation and transcription factor EB (TFEB) occupancy correlate with HDAC-inhibitor-mediated upregulation of PGRN. These findings have implications for epigenetic and cis-regulatory mechanisms controlling human GRN expression and may advance translational efforts to develop targeted therapeutics for treating PGRN-deficient FTD.

Original languageEnglish (US)
Pages (from-to)892-906.e5
JournalCell Chemical Biology
Volume24
Issue number7
DOIs
StatePublished - Jul 20 2017

Fingerprint

Frontotemporal Dementia
Histone Deacetylase Inhibitors
Acetylation
Kinetics
Histone Deacetylases
Up-Regulation
Neurons
Haploinsufficiency
Transcription Factors
Genes
Temporal Lobe
Epigenomics
Mutation
Proteins
Therapeutics

Keywords

  • chemogenomics
  • epigenetic regulation
  • frontotemporal dementia
  • frontotemporal lobar degeneration
  • HDAC inhibitor
  • human neuronal culture
  • optoepigenetic
  • stem cells

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry

Cite this

Selectivity and Kinetic Requirements of HDAC Inhibitors as Progranulin Enhancers for Treating Frontotemporal Dementia. / She, Angela; Kurtser, Iren; Reis, Surya A.; Hennig, Krista; Lai, Jenny; Lang, Audrey; Zhao, Wen Ning; Mazitschek, Ralph; Dickerson, Bradford C.; Herz, Joachim; Haggarty, Stephen J.

In: Cell Chemical Biology, Vol. 24, No. 7, 20.07.2017, p. 892-906.e5.

Research output: Contribution to journalArticle

She, A, Kurtser, I, Reis, SA, Hennig, K, Lai, J, Lang, A, Zhao, WN, Mazitschek, R, Dickerson, BC, Herz, J & Haggarty, SJ 2017, 'Selectivity and Kinetic Requirements of HDAC Inhibitors as Progranulin Enhancers for Treating Frontotemporal Dementia', Cell Chemical Biology, vol. 24, no. 7, pp. 892-906.e5. https://doi.org/10.1016/j.chembiol.2017.06.010
She, Angela ; Kurtser, Iren ; Reis, Surya A. ; Hennig, Krista ; Lai, Jenny ; Lang, Audrey ; Zhao, Wen Ning ; Mazitschek, Ralph ; Dickerson, Bradford C. ; Herz, Joachim ; Haggarty, Stephen J. / Selectivity and Kinetic Requirements of HDAC Inhibitors as Progranulin Enhancers for Treating Frontotemporal Dementia. In: Cell Chemical Biology. 2017 ; Vol. 24, No. 7. pp. 892-906.e5.
@article{bc1ecf61badc4c408d2bd4385f7bf86c,
title = "Selectivity and Kinetic Requirements of HDAC Inhibitors as Progranulin Enhancers for Treating Frontotemporal Dementia",
abstract = "Frontotemporal dementia (FTD) arises from neurodegeneration in the frontal, insular, and anterior temporal lobes. Autosomal dominant causes of FTD include heterozygous mutations in the GRN gene causing haploinsufficiency of progranulin (PGRN) protein. Recently, histone deacetylase (HDAC) inhibitors have been identified as enhancers of PGRN expression, although the mechanisms through which GRN is epigenetically regulated remain poorly understood. Using a chemogenomic toolkit, including optoepigenetic probes, we show that inhibition of class I HDACs is sufficient to upregulate PGRN in human neurons, and only inhibitors with apparent fast binding to their target HDAC complexes are capable of enhancing PGRN expression. Moreover, we identify regions in the GRN promoter in which elevated H3K27 acetylation and transcription factor EB (TFEB) occupancy correlate with HDAC-inhibitor-mediated upregulation of PGRN. These findings have implications for epigenetic and cis-regulatory mechanisms controlling human GRN expression and may advance translational efforts to develop targeted therapeutics for treating PGRN-deficient FTD.",
keywords = "chemogenomics, epigenetic regulation, frontotemporal dementia, frontotemporal lobar degeneration, HDAC inhibitor, human neuronal culture, optoepigenetic, stem cells",
author = "Angela She and Iren Kurtser and Reis, {Surya A.} and Krista Hennig and Jenny Lai and Audrey Lang and Zhao, {Wen Ning} and Ralph Mazitschek and Dickerson, {Bradford C.} and Joachim Herz and Haggarty, {Stephen J.}",
year = "2017",
month = "7",
day = "20",
doi = "10.1016/j.chembiol.2017.06.010",
language = "English (US)",
volume = "24",
pages = "892--906.e5",
journal = "Cell Chemical Biology",
issn = "2451-9448",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Selectivity and Kinetic Requirements of HDAC Inhibitors as Progranulin Enhancers for Treating Frontotemporal Dementia

AU - She, Angela

AU - Kurtser, Iren

AU - Reis, Surya A.

AU - Hennig, Krista

AU - Lai, Jenny

AU - Lang, Audrey

AU - Zhao, Wen Ning

AU - Mazitschek, Ralph

AU - Dickerson, Bradford C.

AU - Herz, Joachim

AU - Haggarty, Stephen J.

PY - 2017/7/20

Y1 - 2017/7/20

N2 - Frontotemporal dementia (FTD) arises from neurodegeneration in the frontal, insular, and anterior temporal lobes. Autosomal dominant causes of FTD include heterozygous mutations in the GRN gene causing haploinsufficiency of progranulin (PGRN) protein. Recently, histone deacetylase (HDAC) inhibitors have been identified as enhancers of PGRN expression, although the mechanisms through which GRN is epigenetically regulated remain poorly understood. Using a chemogenomic toolkit, including optoepigenetic probes, we show that inhibition of class I HDACs is sufficient to upregulate PGRN in human neurons, and only inhibitors with apparent fast binding to their target HDAC complexes are capable of enhancing PGRN expression. Moreover, we identify regions in the GRN promoter in which elevated H3K27 acetylation and transcription factor EB (TFEB) occupancy correlate with HDAC-inhibitor-mediated upregulation of PGRN. These findings have implications for epigenetic and cis-regulatory mechanisms controlling human GRN expression and may advance translational efforts to develop targeted therapeutics for treating PGRN-deficient FTD.

AB - Frontotemporal dementia (FTD) arises from neurodegeneration in the frontal, insular, and anterior temporal lobes. Autosomal dominant causes of FTD include heterozygous mutations in the GRN gene causing haploinsufficiency of progranulin (PGRN) protein. Recently, histone deacetylase (HDAC) inhibitors have been identified as enhancers of PGRN expression, although the mechanisms through which GRN is epigenetically regulated remain poorly understood. Using a chemogenomic toolkit, including optoepigenetic probes, we show that inhibition of class I HDACs is sufficient to upregulate PGRN in human neurons, and only inhibitors with apparent fast binding to their target HDAC complexes are capable of enhancing PGRN expression. Moreover, we identify regions in the GRN promoter in which elevated H3K27 acetylation and transcription factor EB (TFEB) occupancy correlate with HDAC-inhibitor-mediated upregulation of PGRN. These findings have implications for epigenetic and cis-regulatory mechanisms controlling human GRN expression and may advance translational efforts to develop targeted therapeutics for treating PGRN-deficient FTD.

KW - chemogenomics

KW - epigenetic regulation

KW - frontotemporal dementia

KW - frontotemporal lobar degeneration

KW - HDAC inhibitor

KW - human neuronal culture

KW - optoepigenetic

KW - stem cells

UR - http://www.scopus.com/inward/record.url?scp=85023640339&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85023640339&partnerID=8YFLogxK

U2 - 10.1016/j.chembiol.2017.06.010

DO - 10.1016/j.chembiol.2017.06.010

M3 - Article

C2 - 28712747

AN - SCOPUS:85023640339

VL - 24

SP - 892-906.e5

JO - Cell Chemical Biology

JF - Cell Chemical Biology

SN - 2451-9448

IS - 7

ER -